Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
Vincristine Sulfate 1 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. A sterile, colourless solution. |
Each 1 ml contains 1 mg of vincristine sulfate.
Each 2 ml contains 2 mg of vincristine sulfate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| 22-Oxovincaleukoblastine |
Vincristine is an antineoplastic drug with broad-spectrum anti-tumor activity in man. The drug may act by mitotic inhibition, causing an arrest of cell division in metaphase. |
| List of Excipients |
|---|
|
Mannitol |
2 ml Type I clear glass vials, with rubber closures and aluminium caps in packs of 5 vials.
2 ml Type I clear Onco-Tain vials, with rubber closures and aluminium caps in packs of 5 vials.
2.25 ml Type I clear glass, graduated, barrel syringes with luer lock as a single syringe pack.
Not all pack sizes may be marketed.
Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
PL 04515/0008
9th November 2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
